Clinical Trial: Trial to Demonstrate the Equivalence of Two Different Strengths of Oral Centanafadine Capsules in Healthy Subjects

U.S., March 24 -- ClinicalTrials.gov registry received information related to the study (NCT07486895) titled 'Trial to Demonstrate the Equivalence of Two Different Strengths of Oral Centanafadine Capsules in Healthy Subjects' on March 17.

Brief Summary: The purpose of this study is to demonstrate dose strength equivalence of 2 x 164.4 milligrams (mg) centanafadine (CTN) once daily (QD) extended-release (XR) capsules to a 1 x 328.8 mg centanafadine QD XR capsule in healthy adult participants.

Study Start Date: March 08, 2023

Study Type: INTERVENTIONAL

Condition: Healthy Adult Participants

Intervention: DRUG: Centanafadine

Centanafadine will be administered as an oral capsule.

Recruitment Status: COMPLETED

Sponsor: Otsuka Pharmaceut...